An outbreak caused by the SARS-CoV-2 Delta (B.1.617.2) variant in a care home after partial vaccination with a single dose of the COVID-19 vaccine Vaxzevria, London, England, April 2021

We investigated a COVID-19 outbreak of the SARS-CoV-2 Delta variant of concern in a London care home, where 8/21 residents and 14/21 staff had received a single dose of Vaxzevria (ChAdOx1-S; AstraZeneca) vaccine. We identified 24 SARS-CoV-2 infections (16 residents, 8 staff) among 40 individuals (19...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Sarah V, Vusirikala, Amoolya, Ladhani, Shamez N, Fernandez Ruiz De Olano, Elena, Iyanger, Nalini, Aiano, Felicity, Stoker, Kelly, Gopal Rao, Guduru, John, Laurence, Patel, Bharat, Andrews, Nick, Dabrera, Gavin, Ramsay, Mary, Brown, Kevin E, Lopez Bernal, Jamie, Saliba, Vanessa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2021
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268653/
https://www.ncbi.nlm.nih.gov/pubmed/34240699
http://dx.doi.org/10.2807/1560-7917.ES.2021.26.27.2100626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268653/
https://www.ncbi.nlm.nih.gov/pubmed/34240699
http://dx.doi.org/10.2807/1560-7917.ES.2021.26.27.2100626

Ejemplares similares